Showing 21-26 of 26 items.

Sentence	Cancertype
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.	lung
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.	liver
Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer.	breast
Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression.	breast
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality.	unknown
NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells.	A549 cell